In vitro and in vivo studies show that METTL16 knockdown impairs AML initiation and progression, and restricts leukemic infiltration of the bone marrow, spleen, liver, and peripheral blood [27]. The gene discussed is METTL16; the disease is acute myeloid leukemia.